each with different functions and properties that could be harnessed to improve existing hemostatic applications or develop innovative medical products in new therapeutic areas. However ...

The global hemostatic gels market is on a steady growth path, with its value projected to reach USD 1.9 billion by 2032. With rising surgical procedures, increasing trauma cases, and continuous ...

Hospital revenue grew 24% on a reported basis, with standout performance in hemostasis management (26% U.S. revenue growth) and vascular closure through products like VASCADE MVP and MVP XL.

This growth is driven by an increasing volume of surgeries across various medical fields, advancements in hemostatic agents, and the rising demand for efficient blood control products. The growing ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...